METROPOLITAN LIFE INSURANCE CO/NY - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 94 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.29 and the average weighting 0.3%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$71,572
+17.4%
3,493
+13.9%
0.00%
+33.3%
Q2 2023$60,961
+22.7%
3,068
+5.8%
0.00%0.0%
Q1 2023$49,677
-20.8%
2,900
-9.5%
0.00%0.0%
Q4 2022$62,722
+52.1%
3,205
+24.0%
0.00%
+50.0%
Q3 2022$41,241
+16.0%
2,5840.0%0.00%0.0%
Q2 2022$35,556
-13.2%
2,5840.0%0.00%
+100.0%
Q1 2022$40,982
-82.8%
2,584
-76.3%
0.00%
-66.7%
Q4 2021$237,620
-27.0%
10,8850.0%0.00%
-40.0%
Q3 2021$325,353
-32.5%
10,8850.0%0.01%
-28.6%
Q2 2021$482,097
+6.2%
10,885
+6.4%
0.01%0.0%
Q1 2021$453,994
-22.0%
10,232
-3.6%
0.01%
-22.2%
Q4 2020$582,181
+139.9%
10,6160.0%0.01%
+125.0%
Q3 2020$242,682
+9.2%
10,6160.0%0.00%0.0%
Q2 2020$222,193
+50.0%
10,6160.0%0.00%
+33.3%
Q1 2020$148,093
-38.7%
10,6160.0%0.00%
-25.0%
Q4 2019$241,620
+95.4%
10,6160.0%0.00%
+100.0%
Q3 2019$123,676
+1.8%
10,616
+31.1%
0.00%0.0%
Q2 2019$121,455
-6.5%
8,097
+9.4%
0.00%0.0%
Q1 2019$129,849
+18.4%
7,4030.0%0.00%0.0%
Q4 2018$109,712
-39.8%
7,4030.0%0.00%
-33.3%
Q3 2018$182,2627,4030.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$9,851,00011.04%
RTW INVESTMENTS, LP 15,802,802$217,447,0005.62%
Amitell Capital Pte Ltd 97,331$1,339,0003.05%
Prosight Management, LP 276,802$3,809,0003.00%
TANG CAPITAL MANAGEMENT LLC 1,265,900$17,419,0002.64%
Affinity Asset Advisors, LLC 250,466$3,446,0001.45%
COWEN AND COMPANY, LLC 1,000,000$13,760,0001.33%
Boxer Capital, LLC 1,466,051$20,173,0001.28%
Cormorant Asset Management, LP 868,550$11,951,0000.90%
MAVERICK CAPITAL LTD 2,532,366$34,845,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders